Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression

Gamm, MD, PhD, D. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.

Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N. (2017). β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression. Investigative Ophthalmology and Visual Science, 58(1):299-308. doi: 10.1167/iovs.16-20204.